Citation Impact

Citing Papers

Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Monocyte recruitment during infection and inflammation
2011 Standout
Flt3 Signaling-Dependent Dendritic Cells Protect against Atherosclerosis
2011 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
2010
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake
2018 StandoutNobel
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
The Lifelong Effects of Early Childhood Adversity and Toxic Stress
2011 Standout
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications
2008
Prognostic Value of Number and Site of Calcified Coronary Lesions Compared With the Total Score
2008
Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast
2017
Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging
2011
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
2011
Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta‐analysis
2011
Chinese Guidelines for the Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack 2010
2012
Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease
2010
Nonresolving Inflammation
2010 Standout
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Atherothrombosis and High-Risk Plaque
2005
Update on acute coronary syndromes: the pathologists' view
2012
Imaging Atherosclerosis and Vulnerable Plaque
2010
Biodistribution and function of extracellular miRNA-155 in mice
2015 StandoutNobel
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The year in atherothrombosis
2004
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Nanotheranostics for personalized medicine
2012
Myocarditis
2011 Standout
Bladder cancer
2016 Standout
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Third Universal Definition of Myocardial Infarction
2012 Standout
Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study
2006
Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitration
2006
Protective and pathogenic functions of macrophage subsets
2011 Standout
Effects of statins on stroke prevention in patients with and without coronary heart disease: A meta-analysis of randomized controlled trials
2004
Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease
2004
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging
2006
Drug Insight: translating evidence on statin therapy into clinical benefits
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Association Between Visceral Adipose Tissue Area and Coronary Plaque Morphology Assessed by CT Angiography
2010
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Monocytes in atherosclerosis: subsets and functions
2010
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Influence of Atorvastatin Treatment on l -Arginine Cerebrovascular Reactivity and Flow-Mediated Dilatation in Patients With Lacunar Infarctions
2006
ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
2010
Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study
2018
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Immune and Inflammatory Mechanisms of Atherosclerosis
2009
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Routine Screening of Coronary Artery Disease With Computed Tomographic Coronary Angiography in Place of Invasive Coronary Angiography in Patients Undergoing Transcatheter Aortic Valve Replacement
2015
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths
2007 Standout
Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm
2014
Molecular Magnetic Resonance Imaging in Cardiovascular Medicine
2007
Nanotheranostics for personalized medicine.
2012
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Multimodality Cardiovascular Molecular Imaging, Part II
2009
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
EP-2104R: A Fibrin-Specific Gadolinium-Based MRI Contrast Agent for Detection of Thrombus
2008
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel

Works of Marc Sirol being referenced

Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque
2004
Accuracy of 64-Slice Computed Tomography to Classify and Quantify Plaque Volumes in the Proximal Coronary System
2006
Differential Effects of Lipid-Lowering Therapies on Stroke Prevention
2003
Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging
2005
Plaque Imaging and Characterization Using Magnetic Resonance Imaging: Towards Molecular Assessment
2006
Neovascularization in Human Atherosclerosis
2006
DIFFERENTIAL EFFECTS OF LIPID-LOWERING THERAPIES ON STROKE PREVENTION
2003
Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging
2004
Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent
2005
Rankless by CCL
2026